

Hyderabad-based paediatrician Dr Sivaranjani Santosh has played a key role in making an expensive medicine affordable for seven children diagnosed with Allan-Herndon-Dudley syndrome (AHDS), a rare genetic disorder. With support from Access to Medicines India and an international foundation, she helped bring down the annual cost of Tiratricol from as much as Rs. 9 crore to approximately Rs. 2.5 lakh per child. The initiative aims to make treatment more accessible to families who otherwise face an enormous financial burden.
As part of the initiative, all seven children are set to receive a year's supply of Tiratricol completely free of cost on November 30, 2026. The development is expected to provide significant relief to their families, who have been struggling with the high cost of treatment for this rare condition. The effort highlights the importance of collaboration between medical professionals and organisations in improving access to essential medicines for children with rare diseases.























Comments (0)
No comments yet
Be the first to comment!